The Indonesian government has replaced imported COVID-19 vaccines with domestically produced ones that have lower ...
IndoVac, the COVID-19 vaccine manufactured by state-run pharmaceutical company Bio Farma, has received regulatory ...
Indonesia's state pharmaceutical holding company, Biofarma Group, through its subsidiary Kimia Farma, signed a ...
The locally-made COVID-19 vaccine, IndoVac, can already be used for the fourth dose, or second booster vaccinations, ...
The Indonesian Health Ministry allocated 9.3 million doses of the COVID-19 vaccine stock to support the second booster ...
President Director of state-owned pharmaceutical company PT Bio Farma Honesti Basyir stated that his company is aiming ...
The year 2022 marked a new chapter in the journey of the pharmaceutical industry in the country by showcasing the ...
Indonesia has relatively managed to control COVID-19 infections during 2022, despite early this year, facing the third ...
Coordinating Minister for Economic Affairs Airlangga Hartarto expressed belief that the national COVID-19 vaccination ...
State-owned pharmaceutical company PT Bio Farma is still awaiting approval from the government for conducting clinical ...
Bio Farma is ready to produce five million doses of the IndoVac vaccine by 2022-end to support the second booster ...
IndoVac, the COVID-19 vaccine produced locally by state-owned pharmaceutical firm PT Bio Farma, is proof that Indonesia ...
President Joko Widodo (Jokowi) received the second COVID-19 booster vaccine using the domestically produced Indovac ...
Director general for disease prevention and handling at the Ministry of Health, Maxi Rein Rondonuwu, has assured that ...
The National Agency for Drug and Food Control (BPOM) is supporting two of Indonesia’s locally-made COVID-19 ...